Insulet Corporation splits its revenue into 3 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was U.S.Omnipod at $1.9 billion, 71% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Sep 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2017
Dec 31, 2017
|
FY 2016
Dec 31, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3,189
|
2,708
|
2,072
|
1,697
|
1,305
|
1,041
|
904
|
738
|
564
|
464
|
367
|
| U.S.Omnipod |
2,198
+22.4%
share 68.9%
|
1,920
+27.2%
share 70.9%
|
1,509
+20.6%
share 72.9%
|
1,251
+41.4%
share 73.7%
|
885
+35.8%
share 67.8%
|
652
+23.6%
share 62.6%
|
527
+25.3%
share 58.3%
|
420
+30.0%
share 56.9%
|
324
+19.1%
share 57.4%
|
272
share 58.6%
|
—
|
| International Omnipod |
975
+42.9%
share 30.6%
|
754
+44.1%
share 27.9%
|
523
+27.6%
share 25.3%
|
410
+13.0%
share 24.2%
|
363
+0.9%
share 27.8%
|
360
+16.9%
share 34.6%
|
308
+21.7%
share 34.1%
|
253
+47.2%
share 34.3%
|
172
+43.3%
share 30.5%
|
120
share 25.9%
|
—
|
| Drug Delivery |
16
-62.5%
share 0.5%
|
34
-12.3%
share 1.3%
|
39
+8.1%
share 1.9%
|
36
-37.4%
share 2.1%
|
58
-34.2%
share 4.4%
|
87
+25.8%
share 8.4%
|
70
+7.4%
share 7.7%
|
65
-5.3%
share 8.8%
|
68
-5.4%
share 12.1%
|
72
share 15.6%
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PODD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Acton, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1145197
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.